168 related articles for article (PubMed ID: 712115)
1. Reactogenicity and immunogenicity of whole and ether-Tween-split influenza A virus vaccines in volunteers.
Jennings R; Clark A; Oxford JS; Hockley DJ; Potter CW
J Infect Dis; 1978 Nov; 138(5):577-86. PubMed ID: 712115
[TBL] [Abstract][Full Text] [Related]
2. A controlled double-blind comparison of reactogenicity, immunogenicity, and protective efficacy of whole-virus and split-product influenza vaccines in children.
Gross PA; Ennis FA; Gaerlan PF; Denson LJ; Denning CR; Schiffman D
J Infect Dis; 1977 Nov; 136(5):623-32. PubMed ID: 335000
[TBL] [Abstract][Full Text] [Related]
3. The antibody response and immunity to challenge infection induced by whole, inactivated and tween-ether split influenza vaccines.
Potter CW; Jennings R; Clark A
Dev Biol Stand; 1977 Jun 1-3; 39():323-8. PubMed ID: 604115
[No Abstract] [Full Text] [Related]
4. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 1. Short-term immunity.
Clark A; Potter CW; Jennings R; Nicholl JP; Langrick AF; Schild GC; Wood JM; Tyrrell DA
J Hyg (Lond); 1983 Jun; 90(3):351-9. PubMed ID: 6863909
[TBL] [Abstract][Full Text] [Related]
5. Dose-response relationship after immunization of volunteers with a new, surface-antigen-adsorbed influenza virus vaccine.
Potter CW; Jennings R; Phair JP; Clarke A; Stuart-Harris CH
J Infect Dis; 1977 Mar; 135(3):423-31. PubMed ID: 850080
[TBL] [Abstract][Full Text] [Related]
6. A one-year study of trivalent influenza vaccines in primed and unprimed volunteers: immunogenicity, clinical reactions and protection.
Masurel N; Laufer J
J Hyg (Lond); 1984 Jun; 92(3):263-76. PubMed ID: 6736638
[TBL] [Abstract][Full Text] [Related]
7. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 2. Long-term immunity.
Clark A; Potter CW; Jennings R; Nicholl JP; Langrick AF; Schild GC; Wood JM; Tyrrell DA
J Hyg (Lond); 1983 Jun; 90(3):361-70. PubMed ID: 6863910
[TBL] [Abstract][Full Text] [Related]
8. [A new influenza subunit vaccine: reactogenicity and antigenicity in comparison to split and whole virus vaccines (author's transl)].
Kunz C; Hofmann H; Bachmayer H; Liehl E; Moritz A; SchmidtG
Infection; 1976; 4(2):73-9. PubMed ID: 947849
[TBL] [Abstract][Full Text] [Related]
9. Immunity to attenuated influenza virus WRL 105 infection induced by heterologous, inactivated influenza A virus vaccines.
Potter CW; Jennings R; Nicholson K; Tyrrell DA; Dickinson KG
J Hyg (Lond); 1977 Dec; 79(3):321-32. PubMed ID: 270523
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the efficacy of split-product trivalent A(H1N1), A(H3N2), and B influenza vaccines: reactogenicity, immunogenicity and persistence of antibodies following two doses of vaccines.
Ochiai H; Shibata M; Kamimura K; Niwayama S
Microbiol Immunol; 1986; 30(11):1141-9. PubMed ID: 3807793
[TBL] [Abstract][Full Text] [Related]
11. [Local and systemic antibody response after vaccination with 3 different types of vaccines against influenza. II. Neuraminidase inhibiting antibodies (author's transl)].
Werner J; Kuwert EK; Stegmaier R; Simböck H
Zentralbl Bakteriol A; 1980 Feb; 246(1):1-9. PubMed ID: 7424233
[TBL] [Abstract][Full Text] [Related]
12. Inactivated influenza vaccine efficacy: diminished antigenicity of split-product vaccines in mice.
Barry DW; Staton E; Mayner RE
Infect Immun; 1974 Dec; 10(6):1329-36. PubMed ID: 4435958
[TBL] [Abstract][Full Text] [Related]
13. Reactogenicity and immunogenicity of inactivated influenza A (H1N1) virus vaccine in unprimed children. Report to the Medical Research Council Committee on influenza and other respiratory virus vaccines.
Potter CW; Clark A; Jennings R; Schild GC; Wood JM; McWilliams PK
J Biol Stand; 1980; 8(1):35-48. PubMed ID: 6995458
[No Abstract] [Full Text] [Related]
14. Antibody responses and reactogenicity of graded doses of inactivated influenza A/New Jersey/76 whole-virus vaccine in humans.
J Infect Dis; 1977 Dec; 136 Suppl():S475-83. PubMed ID: 342621
[TBL] [Abstract][Full Text] [Related]
15. Comparative trial of influenza vaccines. I. Immunogenicity of whole virus and split product vaccines in man.
Barry DW; Mayner RE; Staton E; Dunlap RC; Rastogi SC; Hannah JE; Blackburn RJ; Nortman DF; Graze PR
Am J Epidemiol; 1976 Jul; 104(1):34-46. PubMed ID: 947145
[TBL] [Abstract][Full Text] [Related]
16. The specificity of the anti-haemagglutinin antibody response induced in man by inactivated influenza vaccines and by natural infection.
Oxford JS; Schild GC; Potter CW; Jennings R
J Hyg (Lond); 1979 Feb; 82(1):51-61. PubMed ID: 105040
[TBL] [Abstract][Full Text] [Related]
17. Serologic responses and systemic reactions in adults after vaccination with monovalent A/USSR/77 and trivalent A/USSR/77, A/Texas/77, B/Hong Kong/72 influenza vaccines.
Quinnan GV; Schooley R; Dolin R; Ennis FA; Gross P; Gwaltney JM
Rev Infect Dis; 1983; 5(4):748-57. PubMed ID: 6622889
[TBL] [Abstract][Full Text] [Related]
18. Clinical reactions and antibody responses to influenza vaccines. A comparison of split or subunit vaccines in children and young adults.
Bernstein DI; Cherry JD
Am J Dis Child; 1983 Jul; 137(7):622-6. PubMed ID: 6858973
[TBL] [Abstract][Full Text] [Related]
19. Neuraminidase inhibiting antibody responses in pigs differ between influenza A virus N2 lineages and by vaccine type.
Sandbulte MR; Gauger PC; Kitikoon P; Chen H; Perez DR; Roth JA; Vincent AL
Vaccine; 2016 Jul; 34(33):3773-9. PubMed ID: 27325350
[TBL] [Abstract][Full Text] [Related]
20. Comparison of new triton X-100- and tween-ether-treated split-treated vaccines in children.
Gross PA; Ennis FA; Gaerlan PF; Denning CR; Setia U; Davis WJ; Bisberg DS
J Clin Microbiol; 1981 Nov; 14(5):534-8. PubMed ID: 7031085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
